☆ 4.6 Review

Outcomes of discontinuing renin-angiotensin system inhibitors: a study protocol for conducting systematic review and meta-analysis

BMJ OPEN (2023)

Related references

Note: Only part of the references are listed.

Article Urology & Nephrology

Hyperkalemia-Related Discontinuation of Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in CKD: A Population-Based Cohort Study

Silvia J. Leon et al.

Summary: Discontinuation of RAAS inhibitors is associated with adverse clinical outcomes in patients with CKD, including high mortality, increased risk of cardiovascular events, and initiation of dialysis.

AMERICAN JOURNAL OF KIDNEY DISEASES (2022)

Add to Collection

Article Transplantation

Renin-angiotensin system blocker discontinuation and adverse outcomes in chronic kidney disease

Carl P. Walther et al.

Summary: Discontinuation of ACEI/ARB therapy among patients with non-dialysis-dependent CKD was associated with a higher risk of death and incident ESKD, indicating a need for further investigations into the causes of therapy discontinuation and evidence-based decision-making.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2021)

Add to Collection

Review Medicine, General & Internal

Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction

Nicole Martin et al.

Summary: Evidence suggests that MRA and ARNI treatment in HFpEF may reduce heart failure hospitalization but have little impact on cardiovascular mortality and quality of life. BB treatment may reduce the risk of cardiovascular mortality, but further trials are necessary. Current evidence for BBs, ACEIs, and ARBs in HFpEF is limited, and their use is not supported in the absence of alternative indications. MRAs and ARNIs are likely effective in reducing heart failure hospitalization, but the treatment effects are modest, highlighting the need for improved patient stratification and new therapeutic approaches.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2021)

Add to Collection

Article Medicine, General & Internal

Association Between Renin-Angiotensin System Blockade Discontinuation and All-Cause Mortality Among Persons With Low Estimated Glomerular Filtration Rate

Yao Qiao et al.

JAMA INTERNAL MEDICINE (2020)

Add to Collection

Review Medicine, General & Internal

What are the risks and benefits of temporarily discontinuing medications to prevent acute kidney injury? A systematic review and meta-analysis

Penny Whiting et al.

BMJ OPEN (2017)

Add to Collection

Article Cardiac & Cardiovascular Systems

Effects of withdrawing vs continuing renin-angiotensin blockers on incidence of acute kidney injury in patients with renal insufficiency undergoing cardiac catheterization: Results from the Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker and Contrast Induced Nephropathy in Patients Receiving Cardiac Catheterization (CAPTAIN) trial

Kevin R. Bainey et al.

AMERICAN HEART JOURNAL (2015)

Add to Collection

Article Medicine, General & Internal

A Randomized Trial of Intensive versus Standard Blood-Pressure Control

Jackson T. Wright et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Add to Collection

Article Medicine, General & Internal

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement

David Moher et al.

SYSTEMATIC REVIEWS (2015)

Add to Collection

Article Medicine, General & Internal

Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure

John J. V. McMurray et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Add to Collection

Article Transplantation

Preoperative angiotensin-converting enzyme inhibitors and angiotensin receptor blocker use and acute kidney injury in patients undergoing cardiac surgery

Steven G. Coca et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)

Add to Collection

Article Urology & Nephrology

Notice

Kidney International Supplements (2012)

Add to Collection

Article Medicine, General & Internal

Prevention, incidence, and outcomes of contrast-induced acute kidney injury

Steven D. Weisbord et al.

ARCHIVES OF INTERNAL MEDICINE (2008)

Add to Collection

Article Urology & Nephrology

The effect of withdrawal of ACE inhibitors or angiotensin receptor blockers prior to coronary angiography on the incidence of contrast-induced nephropathy

Jordan L. Rosenstock et al.

INTERNATIONAL UROLOGY AND NEPHROLOGY (2008)

Add to Collection

Article Medicine, General & Internal

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

BM Brenner et al.

NEW ENGLAND JOURNAL OF MEDICINE (2001)

Add to Collection

© Peeref 2019-2024. All rights reserved.